Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Russo

Showing results (431-440 of 446) with videos related to

Pageof 45
Sort By:
The Pharmacogenomics Journal|May 16, 2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and IdarubicinI Iacobucci, A Lonetti, A Candoni, et al.
Journal of Chemical Theory and Computation|January 19, 2022
WESTPA 2.0: High-Performance Upgrades for Weighted Ensemble Simulations and Analysis of Longer-Timescale ApplicationsJohn D Russo, She Zhang, Jeremy M G Leung, et al.
European Journal of Medicinal Chemistry|July 10, 2025
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studiesR M C Di Martino, D Russo, I Penna, et al.
ESMO Open|December 6, 2025
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trialM Bartoletti, A Passarelli, A Fagotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
ESMO Open|January 4, 2025
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trialB Pellegrino, E D Capoluongo, M Bagnoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
Hematological Oncology|November 18, 2024
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life StudyM Picardi, A Vincenzi, C Giordano, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Living Journal of Computational Molecular Science|May 18, 2023
A Suite of Tutorials for the WESTPA 2.0 Rare-Events Sampling Software [Article v2.0]Anthony T Bogetti, Jeremy M G Leung, John D Russo, et al.
Pageof 45

Showing results (431-440 of 446) with videos related to

Sort By:
Pageof 45
The Pharmacogenomics Journal|May 16, 2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and IdarubicinI Iacobucci, A Lonetti, A Candoni, et al.
Journal of Chemical Theory and Computation|January 19, 2022
WESTPA 2.0: High-Performance Upgrades for Weighted Ensemble Simulations and Analysis of Longer-Timescale ApplicationsJohn D Russo, She Zhang, Jeremy M G Leung, et al.
European Journal of Medicinal Chemistry|July 10, 2025
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studiesR M C Di Martino, D Russo, I Penna, et al.
ESMO Open|December 6, 2025
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trialM Bartoletti, A Passarelli, A Fagotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
ESMO Open|January 4, 2025
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trialB Pellegrino, E D Capoluongo, M Bagnoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
Hematological Oncology|November 18, 2024
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life StudyM Picardi, A Vincenzi, C Giordano, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Living Journal of Computational Molecular Science|May 18, 2023
A Suite of Tutorials for the WESTPA 2.0 Rare-Events Sampling Software [Article v2.0]Anthony T Bogetti, Jeremy M G Leung, John D Russo, et al.
Pageof 45